Page 1,359«..1020..1,3581,3591,3601,361..1,3701,380..»

Nebraska Farmer Back To Work After Knee Stem Cells – Dr Lox

Posted: October 31, 2018 at 4:44 pm

Nebraska Farmer Back To Work After Knee Stem Cells

3 months after having knee stem cells a Nebraska farmer has returned to tending to the daily chores of his farm. Farm life can be rigorous and the knee often takes a lot of the workload. Knee stem cells may be an option when arthritis or osteoarthritis affects the knee. Stem cells may exert many effects, including controlling the immune response and aid in repair or regeneration. Dr. Lox is an expert in stem cell treatments for arthritis and sports injuries. Often patients with advanced degenerative arthritis (osteoarthritis) or known commonly as arthritis may not want a total knee joint replacement. These patients may consider stem cell treatments as a viable option to knee surgery or knee joint replacement. Whether the patient is a farmer in Nebraska or a professional sports athlete all typically want the best quality of life and the highest level of functioning possible.

If youre in pain or had an injury and are looking for an alternative to surgery, contact us immediately at one of our locations. Our Main Medical Center located in Tampa Bay, Florida (727) 462-5582 or at Beverly Hills, California (310) 975-7033.

Read the original here:
Nebraska Farmer Back To Work After Knee Stem Cells - Dr Lox

Posted in Nebraska Stem Cells | Comments Off on Nebraska Farmer Back To Work After Knee Stem Cells – Dr Lox

Frequently Asked Questions – New Mexico Stem Cell Clinic

Posted: October 29, 2018 at 1:41 am

The umbilical cord is processed in the hospital according to the rules and regulations of the American Association of Tissue Banks (AATB). Approximately 4 weeks prior to a scheduled caesarean section, the mothers OB/GYN asks her if she would like to keep and store her unborn childs umbilical cord for future use. If the mother declines, she is asked if she would like to donate the umbilical cord. If she agrees, she undergoes a review of her medical history, social history, and a blood test. If she is deemed an acceptable donor according to prevailing rules of the AATB, then, at the time of her caesarean section, an experienced technician will clamp the umbilical cord, take it to a sterile room, and remove the contents of the umbilical cord and place it into a blood bag. The bag of umbilical cord blood is then delivered to the lab for processing. Once at the lab, a sample of the umbilical cord blood is sent to a 3rd party independent FDA registered lab for testing according to United States Pharmacopoeia rule 71 (U.S.P. 71), which is a test for all known communicable diseases. While that test is taking place, the stem cells are then processed and removed from the red blood cell products. A sample of the finished stem cell product is then sent to a different 3rd party independent FDA registered lab for sterility testing and for the absence of HLA-DR markers. Only after both lab reports come back as clean and the stem cells have passed the regulatory requirements, are the processed umbilical cord stem cells available for distribution.

Continued here:
Frequently Asked Questions - New Mexico Stem Cell Clinic

Posted in New Mexico Stem Cells | Comments Off on Frequently Asked Questions – New Mexico Stem Cell Clinic

Sustainable Table | Genetic Engineering

Posted: October 26, 2018 at 11:45 pm

Genetically engineered (GE) or genetically modified (GM) foods are produced from plants and animals that have had changes made to their DNA, which introduce or modify genetic traits.

Most packaged foods contain genetically modified organisms (GMOs) engineered to be resistant to herbicides and pests; corn, soybeans and canola oil are prime examples. Concerns about GMOs range from their safety to how genetically modified plants pollen effects the environment, to the increasing use of herbicides associated with their use, with decreasing effectiveness. Polls show that consumers want mandatory labels on foods containing GE ingredients.

All living organisms are made up of cells, within which are strings of DNA molecules possessing instructions to make genes, which form a unique blueprint determining how an organism grows, develops, looks and lives. Genes make up about one percent of the DNA sequence; the rest is responsible for regulating when and how quantities of proteins are made.

Genetic engineering (GE) is the direct manipulation of genetic material (or the genome) by artificial means to alter the hereditary traits of a cell or organism. The process can involve the transfer of specific traits, or genes, from one organism to another, including across diverse species. Other types of genetic engineering include removing or switching off certain genes, adding new genes or introducing desired mutations. An organism that is created or modified by genetic engineering is called a genetically modified organism.

Genetic engineering is different from traditional cross-breeding methods, which have been used for millennia. Traditional breeding more closely resembles accelerated evolution: breeders select organisms with a desired trait and then further select and breed whichever of its offspring most exhibits that trait. A breeder seeking a disease-resistant tomato, for example, will grow many tomatoes, but save the seeds of only the most disease-resistant plants. After several generations, offspring will be much more disease resistant than the progenitor. Traditional breeding is done between the same or closely related species and keeps strands of DNA and gene sequences intact which can also mean that negative traits are reproduced alongside positive traits. Through genetic engineering, on the other hand, it is possible to isolate a single gene out of the whole genome and insert it into another organism.

The future of genetic engineering appears to be even more targeted than that: CRISPR technology (which stands for Clustered Regularly Interspaced Short Palindromic Repeat) allows scientists to isolate and essentially cut and paste very specific sections of DNA. This makes the process much more precise and efficient and inexpensive, making it easier for many more scientists to experiment with the technology. As it becomes more common, many scientists also urge caution, as unintended consequences, whether at the cellular, human or ecosystem level, cannot be known in advance.

Genetically engineered crops have been adopted at an exceptionally rapid rate. In 1997, 17 percent of US soybean acres were planted with GE varieties; by 2014, that figure rose to 94 percent. GE cotton usage went from 10 percent in 1997 to 91 percent in 2014. GE corn acreage increased from 25 percent in 2000 to 92 in 2017.

The vast majority of these crops have been engineered to tolerate herbicides, allowing the plants to be sprayed with a particular chemical while the surrounding weeds die. Glyphosate, the active ingredient in Roundup, is the most common. Other crops are engineered to produce their own natural pesticide (primarily to produce Bacillus thuringiensis, or Bt, a naturally-occurring bacterium that is lethal to a number of agricultural pests), to increase drought resistance or improve nutritional content. The AquAdvantage Salmon, the first GE animal approved for human consumption, was engineered for faster growth, so that it reaches market weight more quickly than a natural salmon.

In addition to corn, soybeans and cotton, the other GE crops that are commercially available in the US are potatoes, papaya, squash, canola, alfalfa, apples and sugar beets. Several others are USDA approved but are not currently produced, including tomatoes, (non-sugar) beets, rice, roses, flax, plums and tobacco. The controversial hormone rBGH (recombinant bovine growth hormone), which increases milk production in dairy cows, is genetically engineered as well.

The FLAVR SAVR tomato, engineered to retain real tomato taste after shipping, was the first GE food approved for human consumption by the US Department of Agriculture (USDA), in 1992, but has since been taken off the market. Most recently, the Impossible Burger a meatless burger that uses a genetically engineered yeast to make its signature ingredient known as heme (which accounts for its meat-like flavor) has been popping up on menus and causing controversy because it does not have FDA approval.

In the US, regulatory approvals for GMOs are a complicated patchwork of the Food and Drug Administration for pharmaceutical developments, the Environmental Protection Agency for insecticide uses and the USDA for food crops.

For many farmers, GE crops require much less work and provide a larger yield, which offsets the substantially higher cost of GE seed. One 2014 metastudy found that globally, GE crops have reduced pesticide use by 37 percent, increased crop yields by 22 percent and increased farmer profits by 68 percent. It is important to note that it was insect-resistant Bt crops that had much more advantage than herbicide-tolerant crops (from Roundup Ready seeds).

A 2014 analysis of USDA data had similar findings for insect-resistant crops in the US, but many more mixed results on herbicide resistance. Certainly, when farmers start with GE seeds, yields and profits increase in the first few years. But some studies show that this tapers off. For reasons discussed below, GMO technology is problematic for farmers and consumers alike.

On a larger scale, corporate interest plays an enormous role in the rapid growth of the technology. In 1980, the Supreme Court ruled that scientists could patent a GE bacterium developed to break down oil spills. This ruling stating that life itself could be patented and owned gave companies an incentive to develop GMOs that could be useful and profitable.

Monsanto (now part of Bayer ), the largest manufacturer of GMOs, has a long history as a chemical maker, including as one of several makers of Agent Orange, the highly toxic defoliant used during the Vietnam War. Following the war, the company turned to making agricultural chemicals, including its bestseller glyphosate herbicide, Roundup, and experimenting with genetically modifying seeds to resist the chemical so that pesticides could be liberally applied without fear of killing the crops. It introduced Roundup Ready seed in 1996 and spun off its chemical operations two years later to focus on biotechnology.

In 2017, Monsantos net sales of GE corn, soybean and cotton seeds and traits totaled $9.5 billion. Most troubling, in the last two decades, is that Monsanto has bought many competitor seed companies, giving it control of a wide swath of the seed market and its accompanying genetic diversity. In 2018, Monsanto was bought by Bayer, further consolidating the production and ownership of seed stocks around the world.

The biotech industry claims that this chemical-based agricultural technology and biotechnology is necessary to feed a growing world population, increase crop yields and adapt to a changing climate. Herbicide-resistant crops do not require tilling, which leaves carbon in the ground and is better for soil structure, and proponents claim that they require less pesticide application than non-GE crops. However, this does not tell the whole story. These crops have actually driven up the use of herbicides like glyphosate, thereby increasing weed resistance and leading to the reintroduction of more potent herbicides. These false narratives are perpetuated by biotech and other agribusiness corporations, but also by land grant universities (which receive more funding from agrochemical companies than public dollars ), many agricultural scientists and farm organizations.

However, technology and the industrialized food system are not currently feeding the world, so there is reason for skepticism about this claim. Globally, agriculture produces more than one and a half times the number of calories needed to feed the world population, yet one in nine people goes hungry. The profit motive of Bayer/Monsanto and other agrochemical companies, as well as their long lack of support for small farmers, should subject their claims of working solely for the public good to scrutiny.

When it comes to increasing calorie production for the parts of the world that sorely need to feed a hungry populace, the International Assessment of Agricultural Knowledge, Science and Technology for Development report from the United Nations proposes that organic and sustainable agriculture is the best solution for countries like Africa and India, where the need is greatest.

Much of the debate around genetically modified food crops and animals focuses on potential threats to human health. But, long-term studies of the impact of consuming GM foods have yet to be done. Some independent studies have documented health effects on animals from eating GMO foods, which have become the subject of controversy.

Companies have determined that GE crops are different enough from those derived by conventional crops to get a patent, but not different enough to require adequate safety testing before they get to market. Additional independent studies and testing are needed. Ways in which GE foods can cause health problems are already documented, particularly in terms of allergens: genes from an allergenic plant can transfer the allergen to the new plant, causing it to provoke a reaction in those sensitive to the first plant. It is also possible that new allergens could be created from combinations of genes that did not previously exist. Overall, though, we do not understand all of the potential health concerns, but that uncertainty is enough to warrant more oversight, not less.

Perhaps the most concerning consequence of herbicide-resistant crops is the huge increase in herbicide use and the evolution of herbicide-resistant superweeds. Weeds resistant to glyphosate, which have survived annual use of the herbicide, have become a problem. A 2016 survey across the Midwest found that one third to upwards of three quarters of fields showed resistant weeds. To address the problem, seed and chemical companies have turned to older chemicals such as 2,4D and dicamba, engineering seeds resistant to these more toxic compounds and increasing their use in farmers fields.

Contrary to industry promises that GE crops would require less pesticide application, chemical use has increased steadily, particularly by farmers growing herbicide-resistant crops. Farmers growing Bt pest-resistant crops have been able to decrease their insecticide use, but scientists are concerned that the effect may not last, as pests also evolve resistance.

One of the major ways that GMOs have impacted the environment, therefore, has been in a mass of side effects stemming from increased pesticide use, including compromised water quality, loss of biodiversity and threats to human health.

While biotech seeds are touted as the only way to feed a growing world population, the data on yields are mixed. It should also be noted that GE crops rely on the promise of reduced pest and weed pressure to boost yields; no successful GE technique has yet increased intrinsic yields (such as more kernels per corncob).

A 2008 literature review by the Union of Concerned Scientists found that herbicide-tolerant GE crops produced no yield gain, while Bt crops produced marginal increases. A 2013 New Zealand study found that average US GE corn yields were slightly lower than non-GE corn yields in western Europe in the same period. 2016 studies by both the National Academies of Sciences and the New York Times found no evidence that yield increases could be tied to GM technology.

Meanwhile, traditional plant breeding techniques have increased yields significantly and have even outperformed GE technology in improving drought tolerance and other factors necessary for farming in a warming climate. But investment in GE research means less funding going to these more promising methods.

Farmers adopt GE seeds and their attendant herbicides ostensibly to make farming easier and more profitable. However, GE seeds cost a lot more than conventional seeds (up to $150 more per bag, according to one report) plus the cost of herbicides. An analysis by AgriWize farm business consultant Aaron Bloom found that GM corn costs an average of $81 more per acre per season than conventional. For many farmers, the yield increase at harvest time makes the upfront costs worth it, but for others, the proliferation of superweeds or simply one bad harvest can put them in debt, with few options for how to get off the GE treadmill.

Congress passed the Plant Patenting Act in 1930, as the rise of hybrid seeds made the business of selling seeds (which since time immemorial have been freely reproducible) profitable for the first time. The law applied to certain plants only, but in 1985, it was expanded to include not only all crops but also their cells, genes and DNA. Seed patents, along with laws on intellectual property, seed marketing and more, have exploded in years since.

Humans have been breeding seeds for aeons, making plants more productive, tastier and better adapted to local conditions. In fact, adaptation has been bred into seeds throughout the ages by subsistence farmers; we take ancient farmer breeding ingenuity for granted. Todays seed patents, meanwhile, bestow rights and profits on multinational companies for discovering the newest traits, ignoring the long and unsung contributions of farmers localized agricultural knowledge.

Patents and other legal measures put control of this long heritage of seed development, and therefore our future food security, in the hands of a very few companies. The seed industry is one of the most concentrated in the US economy. Almost 80 percent of corn and more than 90 percent of soybeans grown in the US feature Monsanto/Bayer seed traits, while the top three seed firms control more than half of the total seed market, with Monsanto/Bayer alone controlling one quarter. Up-to-date numbers on seed market control are difficult to come by, however, because huge mergers in the industry, including the 2017 Dow/Dupont and the 2018 Monsanto/Bayer mergers have shifted the landscape.

These companies value their patents and other intellectual property highly. Monsanto/Bayer has filed suit against 147 farmers for violating the terms of their planting agreement and has also at times threatened or intimidated farmers.

Surveys consistently show that upwards of 90 percent of Americans support labeling of GMO foods, but unlike most developed countries including 28 nations in the European Union, Japan, Australia, Brazil, Russia and China the US had for many years no federal requirement for labels. States responded by taking the matter into their own hands. More than 70 labeling bills or ballot initiatives were introduced across 30 states, and labeling laws were passed in Vermont, Connecticut and Maine. In high-profile cases in Washington State and California, bills were defeated due to aggressive lobbying efforts by big food and biotechnology companies to the tune of $63.6 million in 2014.

In 2016, a federal law was passed, mandating labeling of GE ingredients in foods, which strikes down or pre-empts state labeling laws. The federal laws many critics dubbed it the Denying Americans the Right to Know (DARK) Act, because not only does it override state efforts (which in some cases, as in Vermont, are stringent), but because many GMOs would be exempted from being labeled. Further, the federal law states that labeling can be in the form of a digital QR code or toll-free phone number rather than a textual label that clearly marks the product as containing GMOs.

Read more from the original source:
Sustainable Table | Genetic Engineering

Posted in Genetic Engineering | Comments Off on Sustainable Table | Genetic Engineering

Stem Cells for Hip Brookfield, WI | Wisconsin Stem Cell …

Posted: October 26, 2018 at 10:47 am

Stem Cell Therapy for General Hip Pain

Hip pain is a common problem that affects many people making it difficult to walk, stand and sit. Hip pain has many causes, making it essential to be evaluated properly to find the true cause. There are many conditions that can cause hip pain, including osteroarthritis, bursitis, tendonitis, and osteonecrosis.

Wisconsin Stem Cell Therapys doctors have extensive experience when it comes to hip pain treatment. We have pioneered the industrys latest proven alternatives to surgery and steroids. Our in-office, same-day procedures will alleviate your hip pain regardless of the cause. Our revolutionary platelet rich plasma (PRP) and regenerative cell procedures treat all the damage and underlying conditions that cause you pain. Our surgeons use stem cell therapy to rebuild and strengthen the damaged tissue of your hip, eliminating your pain and improving your quality of life.

Osteoarthritis of the hip results from years of wear and tear. Cartilage provides a buffer in the joint between the bones to allow smooth, easy movement. Over time, this cartilage begins to break down and become brittle. Without enough cartilage to protect the bones from rubbing together and causing damage, this friction leads to swelling and painful inflammation. Ultimately, stiffness and soreness can limit mobility, and make moving the joint very painful.

Traditionally, hip pain has been difficult to treat, with pain medications, steroid injections, or even surgery being the best possible treatment options. Fortunately, recent developments in technology and medicine make it possible to treat osteoarthritis pain naturally. Stem Cell Therapy cells are powerful healing agents that, when used in concentrated doses, can quickly reduce inflammation and scar tissue, and enhance the natural healing processes of the body. Regenerative Cell Therapy is a non-invasive, in-office procedure that safely and effectively alleviates osteoarthritis pain.

A labrum tear is caused in many different ways. Sports injuries are the main cause of labrum tears. The reason is that the outermost part of the labrum attaches directly to the tendon. So the athletes who use a lot of force and motion such as weightlifters, golfers and baseball pitchers are at high risk of this type of injury.

Traumatic injury is the most common cause of a tear. Traumatic injury may result from a situation such as falling in a manner that puts strain on the hip or a direct blow or sudden pull. Furthermore, a labrum tear can result from degradation of the cartilage from overuse, repetitive motion and a dislocated hip.

If you are suffering from labrum tear, you can visit us for a painless alternative to cortisone injections and/or surgery. After undergoing our procedure it will take you a very short time to recover. Wisconsin Stem Cell Therapys procedure for labrum tears includes stem cell therapy. This procedure reduces the risk associated with traditional surgery and treats the underlying damage causing the pain. These cells accelerate the healing process by making the conditions in the affected area more conducive to repair and stimulating the movement of regenerative cells towards the site of inflammation.

The hips are often the most used joint in the body, and over time take a lot of wear and tear. Hip degeneration is a condition that usually develops and worsens over a long period of time and with the aging process. Some may not notice any symptoms in the first stages, and then they may appear suddenly. When the cartilage protecting and surrounding the hip bones begins to wear down, those bones can begin to rub together. This friction between the bones eventually causes severe pain, inflammation, and swelling. It may cause stiffness, limit the joints range of motion, or even lead to the development of bone spurs.

Advanced developments in regenerative medicine now make it possible to effectively treat pain from hip degeneration without prescription medications or steroid injections. In many cases, it may even help some sufferers avoid high-risk surgeries. Procedures like Stem Cell Therapy take regenerative cells and use them to heal specific areas of damaged tissue. When inflammation and aging slows down the natural production of these cells, providing the body with them in concentrated levels quickly reduces pain, inflammation, and scar tissue. This process provides support for the immune system to help heal damage and degeneration within the hip joint.

Inside the larger joints of the body are small, fluid-filled sacs called bursae that provide cushioning between muscles, bones and tissues, allowing them to move smoothly without friction. Bursitis is a condition involving the inflammation of one or more of these bursae. It can occur within the hip joints, causing mild to severe pain and stiffness, while making movement uncomfortable.

Treatment for bursitis should first reduce the inflammation that is causing the pain and stiffness in the hip joint. Stem Cell Therapy is one of our advanced treatment options that takes concentrated amounts of healing cells, and uses them to treat the specific area of inflammation and damage. Stem Cell Therapy is a revolutionary solution to heal degeneration of soft joint tissues and a safe alternative to medications, steroid injections, and surgery. This is a non-surgical procedure that can be done in-office to quickly and naturally alleviate your hip pain.

See the article here:
Stem Cells for Hip Brookfield, WI | Wisconsin Stem Cell ...

Posted in Wisconsin Stem Cells | Comments Off on Stem Cells for Hip Brookfield, WI | Wisconsin Stem Cell …

Stem Cell Therapy in Annapolis Maryland | Stem Cell …

Posted: October 25, 2018 at 2:45 pm

Across the country joint pain can not only be unbearable but difficult to treat. The Annapolis Maryland area is no exception. Surgery is often the only way to help reduce the pain but often requires an invasive procedure that will require an extended recovery period. With advancementsin stem cell therapy many individuals of choosing this alternative over the complex surgeries with greater success.

Stem cell therapy is the process of injecting stem cells into the painful joints, which promotes a regeneration process where the body begins to heal itself. The stem cell used in this process are amniotic stem cells that are retrieved only from C-section births. Retrieving the stem cells through the C-section birth means no harm is inflicted on the mother or child during the process. Stem cell therapy has been used to help treat a wide range of joint pains in the knee, hip, shoulder, and wrists.

Shoulder pain is often ignored until the pain becomes too unbearable to function properly throughout the day. Often times, the only treatment to help correct the shoulder pain is through a risky and invasive surgery. Many times the surgeries are not successful and will only provide temporary relief to the patients.

Stem cell therapy, however, can be a more successful alternative to shoulder surgery. Stem cell therapy is a non-invasive procedure that is done in just one day. There is no complex surgery or prolonged recovery time.

Stem Cell Therapy can help relieve these common shoulder conditions:

Many times the aches and pains in the knee are caused from overworking the joints, which is typically from just everyday wear and tear. The aches can quickly turn into severe pains that limit the mobility of the knee. At the onset of these aches and pains cortisone shots can be recommended to allow temporary relief of the pain but, over time they become ineffective and the individual is left with no other choice but to have knee surgery.

Stem cell therapy can provide a long lasting relief for individuals who suffer from knee pain. The amniotic stem cell injects can help regenerate the damaged cells in the knee and because they contain hyaluronic acid the joints are well lubricated allow for quick pain relief and restored mobility.

Stem Cell Therapy can help relieve these common knee conditions:

Any hip injury can cause severe pain to the individual and can often require ongoing pain management without surgery. Stem cell therapy can provide a much more effective alternative for individuals suffering from hip pain. The stem cell injection can promote a natural regrowth to cells and tissue causing the pain.

Stem Cell Therapy can help relieve these common hip conditions:

You need your hands and wrist to perform just about any daily activity so having a risky surgery that will have you without the function of one of your hands for months is not an ideal option. Stem cell therapy can allow individuals to have the full use of the hands with a noninvasive and effective injection,

Stem Cell Therapy can help relieve these common wrist conditions:

See the original post here:
Stem Cell Therapy in Annapolis Maryland | Stem Cell ...

Posted in Maryland Stem Cells | Comments Off on Stem Cell Therapy in Annapolis Maryland | Stem Cell …

Biotechnology – American Farm Bureau Federation

Posted: October 16, 2018 at 7:45 pm

Biotechnology has proven to be an important tool for better sustainability and food security. It helps farmers grow more food while improving the environment. For example, biotechnology reduces the use of costly inputs and improves weed management, allowing farmers to reduce tillage for better soil, water and air quality. Today, roughly 90 percent of corn, cotton and soybeans grown in the U.S. have been improved through biotechnology, and farmers are choosing biotech traits when growing other crops such as alfalfa, sugarbeets and canola.

Despite rapid adoption by farmers and a strong scientific consensus that biotechnology does not pose health and environmental risks, regulatory burdens are slowing research and innovation of new biotech traits and are starting to reduce U.S. farmers international competitive advantage. In addition, activist groups routinely threaten the availability of new traits by blocking science-based regulatory decisions, filing lawsuits and advocating for labeling mandates.

GM crops require less water and fewer chemical applications than conventional crops, and they are better able to survive drought, weeds, and insects.

U.S. agriculture will maintain its competitive advantage in world markets only if we continue to support innovations in technology and grasp opportunities for future biotech products.

To improve regulation of biotechnology, Farm Bureau supports:

Farm Bureau encourages efforts to educate farmers to be good stewards of biotech crops to preserve accessand marketability.

Farm Bureau believes agricultural products grown using approved biotechnology should not be subject to mandatory labeling. We supportexisting FDA labeling policies and opposestate policies on biotech labeling, identification, use and availability.

On July 29, 2016 the president signed S. 764, the National Bioengineered Food Disclosure Standard, into law. While not perfect, S. 764 was a compromise that Farm Bureau endorsed. The law creates a uniform standard for the disclosure of ingredients derived from bioengineering and allows food companies to provide that information through an on-package statement, symbol or electronic disclosure. It also created a strong federal preemption provision to protect interstate commerce and prevent state-by-state labeling laws and was effective on the date of enactment. USDA has two years to develop the disclosure standards and Farm Bureau has been an active participant in the rulemaking process.

Farm Bureau supports active involvement and leadership by the U.S. government in the development of international standards for biotechnology, including harmonization of regulatory standards, testing and LLP policies.

This resource can help set the record straight on GMOs, to correct misinformation and show why biotechnology is so important to agriculture.

Benefits of Biotech Toolkit (PDF)

Continue reading here:
Biotechnology - American Farm Bureau Federation

Posted in Biotechnology | Comments Off on Biotechnology – American Farm Bureau Federation

Benefits of Genetic Engineering | Chemistry Learning

Posted: October 14, 2018 at 8:44 pm

The production of technologies based on genetic engineering is often referred as modern biotechnology. With the improvement of genetic engineering ....

Genetic engineering facilitates the manipulation and duplication of DNA pieces, for industrial, medical and research purposes. Genetic engineering has produced a revolution in molecular biology. Benefits of Genetic Engineering are experienced in whole array of fields especially in agriculture, in production of valuable proteins and vaccine production.

Pic Credit : Link

The production of technologies based on genetic engineering is often referred as modern biotechnology. With the improvement of genetic engineering techniques, the time for generating and evaluating new germplasm (a collection of genetic resources for an organism) can be drastically reduced. Genetic engineering may ultimately have their most significant effect on agriculture. Recent advances have raised possibility of development of new plant germplasm through introduction of any gene from any organism into plant.

With respect to agriculture, modern biotechnology has been considered as the second phase of green revolution. Organisms whose genes have been altered by manipulation are called genetically modified organism (GMO). The working of GMO is due to nature of transferred genes, nature of host organism and food web formed. Some useful benefits of genetically modified plants in agricultural biotechnology are:

The first genetically modified food was Flavr Savr Tomato which was resistant to rotting.

Pic Credit : Link

Another genetically modified food is golden rice (Pro Vitamin A enriched). Several other genetically modified foods include, soybeans, corn, cotton, seed oil etc have been formed. But many controversies are associated with genetically modified food including environment and human safety, ethics, food security, poverty reduction etc.

Some success has been achieved in developing varieties resistant to herbicides, viral diseases and insect pest. Genetic engineering promises rapid acceleration of plant breeding efforts for crop improvement.

Another benefit of genetic engineering is realized in production of valuable proteins. Recombinant DNA made possible the use of bacteria to produce proteins of medical importance. One such example is that of genetically engineered human insulin which is of great importance and now marketed throughout the world.

Some important genetically engineered proteins include:

Human InsulinHuman insulin or Humulin has great importance. Earlier, patients could not tolerate pig insulin, as it has slightly different amino acid sequence as compared to human. Humulin eventually became cheaper than that extracted from animal pancreas and is now available.

InterferonInterferon is an antiviral agent which is secreted by cells which are attacked by virus. Several types of genetically engineered interferon are available in market and gives rise to antitumoral effect (thwarting formation of cancerous tumors).

Growth hormoneIn humans, growth hormone helps in treatment of hypopituitary dwarfs. Genetically engineered growth hormones may prove useful in the treatment of bone fractures, skin burns and bleeding ulcers of digestive tract. The human hormone is marketed in United States and bovine hormone is expected to yield bigger cattle and thus more beef. Hence growth hormones are commercially very demanding.

Vaccines produced by genetic engineering offer an advantage that the microbial strains from which the proteins are extracted do not contain complete viruses. And thus, there are no risks of accidental inoculation with live virus.

Cloning directly into vaccinia virus DNA holds great promise, although vaccines so produced are not yet in the market. Recombinant vaccinia viruses for example, a gene from genital herpes virus within its DNA, can multiply and can subsequently be inoculated into humans. The vaccinia virus produces mild infection, and expresses some of herpes virus protein and produces immunity. This is very similar in a way to what Edward Jenner did over 100 years ago when he introduced the first vaccination scheme, which eventually led to the extinction of smallpox.

Vaccines can be produced using recombinant DNA technology or using cell culture. Vaccines of common use are usually produced by cell cultures or animals. Such vaccines contain weakened or inactivated pathogens. Crop plants can bear cheaper bioreactors to produce antigens to be utilized as Edible vaccines. These edible vaccines are said to be a cheap alternative as compared to recombinant vaccines.

The transgenic plants are treated as edible vaccines and consumption of these transgenic plants viz. transgenic banana and tomato cure diseases like Cholera and Hepatitis-B. Foot and mouth diseases can be cured by feeding them transgenic sugar beet. In the near future, these vaccines can be used as conventional vaccines.

Humulin was the first therapeutic product to be made commercially by genetically engineered bacterium. Recently a genetically engineered malarial vaccine SPF 66 has been produced.

Genetic engineering, promises to have an enormous impact on the improvement of crop species. Genetic transformation can boost plant breeding efforts for developing disease resistant varieties. Now the disease resistant genes can be isolated and transferred to high yielding susceptible plants to produce pathogen free plants. Through gene sequencing, it is possible to locate gene and after identification, gene is isolated and transferred to the host. Several disease resistant somaclones have been identified for resistance to severe potato disease, early blight of potato, caused by Alternaria Solani. Scientists are using Agrobacterium gene transfer system to produce tobacco plants with increased resistance to Tobacco Mosaic Virus (TMV).

Insect resistant plants are also developed, using biotechnological applications. Several biopesticides are developed e.g. Bt cotton, Bt corn, rice, tomato, potato, and soybeans etc.

Process of Insertion of Bt gene in corn to make it resistant from insect attack

Pic Credit : Link

Bt signifies Bacillus thuringiences. This bacterium contains insect toxin gene. Bt toxin gene is cloned from the bacteria and expressed in plant to provide resistance from insects, without requirement of insecticides. These modified disease resistant plants are called transgenic plants.

Mar 11, 2009admin

Continued here:
Benefits of Genetic Engineering | Chemistry Learning

Posted in Genetic Engineering | Comments Off on Benefits of Genetic Engineering | Chemistry Learning

Stem Cell Doctors Delaware, Stem cell injections, Stem …

Posted: October 14, 2018 at 8:42 pm

Stem cells are a particular sort of cells that have the capacity to repeat and recover themselves inside the human body. Grown-up mesenchymal foundational microorganisms work as a sort of interior repair framework, having the capacity to separate to recharge different cells. These regenerative cells have the one of a kind ability to remain an undifferentiated cell or turn into another sort of cell with a particular capacity inside the human body, for example, bone, ligament, muscle or skin cells. Given their great and extraordinary regenerative nature, fat inferred regenerative cell treatment offers new potential in the treatment of specific signs.

Delaware, USA a small Mid-Atlantic U.S. state, sits on a peninsula marked by dune-backed beaches bordering the Atlantic Ocean, Delaware River and Delaware Bay. In Dover, the capital, First State Heritage Park encompasses 18th-century Colonial landmarks like the Georgian-style Old State House.

Stem cells have the capability to modify into specific cell types. There are two defining characteristics of a stem cell are perpetual self-renewal and the ability to differentiate into a specialized adult cell type.

We offer a complete way to deal with construct their training by teaching people in general in a straightforward way. Our careful screening process insures doctors a high quality treatment for patients suffering from inflammatory and degenerative conditions.

For further information about our systems or doctors Contact us today.

See the article here:
Stem Cell Doctors Delaware, Stem cell injections, Stem ...

Posted in Delaware Stem Cells | Comments Off on Stem Cell Doctors Delaware, Stem cell injections, Stem …

IEEE-NANOMED 2016 The 10th IEEE International Conference …

Posted: October 13, 2018 at 8:45 am

Holiday Inn Macao Cotai Central Sands Cotai Central, Cotai Strip, Taipa, Macau SAR, China

Program Timetable (PDF version) is available. (FINAL, updated on Oct 26)

Registration Time:

IEEE-NANOMED is one of the premier annual events organized by the IEEE Nanotechnology Council to bring together physicians, scientists and engineers alike from all over the world and every sector of academy and industry, working at advancement of basic and clinical research in medical and biological sciences using nano/molecular and engineering methods. IEEE-NANOMED is the conference where practitioners will see nano/molecular medicine and engineering at work in both their own and related fields, from essential and advanced scientific and engineering research and theory to translational and clinical research.

Conference Theme:

Authors are also invited to submit results to a special issue of the journal Micromachines (impact factor 1.295), on the topic of Microdevices and Microsystems for Cell Manipulation. More information on the special issue and paper submission can be found here:http://www.mdpi.com/journal/micromachines/special_issues/cell_manipulation

Authors are also invited to submit results to a special issue of the journal Micromachines (impact factor 1.295), on the topic of MEMS/NEMS for Biomedical Imaging and Sensing. More information on the special issue and paper submission can be found here:http://www.mdpi.com/journal/micromachines/special_issues/MEMS_biomedical_imaging_sensing

Continued here:
IEEE-NANOMED 2016 The 10th IEEE International Conference ...

Posted in Nano medicine | Comments Off on IEEE-NANOMED 2016 The 10th IEEE International Conference …

HB810 | Right to Try Law | Texas Stem Cell Law | StemGenex

Posted: October 13, 2018 at 8:45 am

June 12, 2017

House Bill (HB810) on stem cell therapy has passed in the Texas state legislature and become law. Patients in Texas will now have access to this Right to Try innovative form of therapy for those suffering with debilitating and incurable illnesses.

Rita Alexander, Chief Administrative Officer at StemGenex Medical Group in La Jolla, CA, applauded Texas for this landmark legislation and Republican State Rep. Drew Springer, R-Muenster, who strongly advocated for this bill. She noted that over the past three years, Right to Try advocates in 33 states have helped enact legislation to eliminate obstacles for terminally ill patients seeking treatments that may not be approved by the Food and Drug Administration (FDA).Those advocates are showing considerable momentum in the remaining 17 states, potentially expediting clinical therapies for patients who have limited options with current Texas stem cell laws.

At StemGenex, we are committed to helping people achieve optimum health and better quality of life through the healing benefits of their own stem cells, said Alexander. Specifically, we use adipose-derived adult stem cell therapy for patients battling conditions such as Multiple Sclerosis, Parkinsons disease, COPD, Rheumatoid Arthritis and Osteoarthritis. We are also committed to the science of stem cell therapy and sponsor five clinical outcome studiesregistered with theNational Institute of Health (NIH) for these diseases.

What I personally witnessed before the start of StemGenex were patients who had exhausted conventional medical treatments but wanted to try alternative therapies. I was one of them, suffering from severe Rheumatoid Arthritis. Ihad only three options; I could seek a clinical trial, travel to outside of the U.S. to try alternative therapies such as stem cell treatment or petition the FDA for access to drugs under the agencys expanded access, or compassionate use program. Now, new state laws like the one just passed in Texas, built on model legislation from the Goldwater Institute in Arizona, will allow doctors and patients to make their own informed decisions on treatments that have cleared the safety phase of FDA testing.

Last year, in a move that was seen by some as a response to Right to Try laws, the 21st Century Cures Act, a landmark piece of legislation focused on medical innovation and medical research, was signed into law by President Obama. This Act provides the FDA with the flexibility to accelerate how it evaluates regenerative medicine treatments, such as stem cell therapies, while maintaining its high standards of safety and efficacy.

Were on the cusp of a major change on how patients can access stem cell therapy, saidAlexander. Today, new treatments and advances in research are giving new hope to people affected by a wide range of autoimmune and degenerative illnesses, said Alexander. StemGenex Medical Group is proud to offer the highest quality of care and to potentially help those with unmet clinical needs improve their quality of life.

To find out if you are a candidate for treatment or to learn more about stem cell laws,Call (855) 742-7836to speak with a Patient Advocate or visitwww.StemGenex.com.

Originally posted here:
HB810 | Right to Try Law | Texas Stem Cell Law | StemGenex

Posted in Texas Stem Cells | Comments Off on HB810 | Right to Try Law | Texas Stem Cell Law | StemGenex

Page 1,359«..1020..1,3581,3591,3601,361..1,3701,380..»